Latest news
Getting to the heart of the matter - bangkokpost.combangkokpost.com · Tue, 11 Aug 2026 00:10:00 GMTUnapproved in US for decades, levosimendan stumbles in phase 3 as Tenax eyes narrow FDA path - Fierce PharmaFierce Pharma · Mon, 10 Aug 2026 20:40:16 GMTTenax’s levosimendan fails Phase III LEVEL trial in PH-HFpEF - AllSciAllSci · Mon, 10 Aug 2026 16:40:47 GMTCardiomyopathy Following Olanzapine Use in an Octogenarian: A Case Report and Literature Review - CureusCureus · Mon, 10 Aug 2026 16:36:24 GMTTNX-103 Misses Primary Endpoint in Phase 3 LEVEL PH-HFpEF Trial - HCPLiveHCPLive · Mon, 10 Aug 2026 15:03:24 GMTNearly Half of Heart Failure Cases Weren't Caught Until an Emergency, and a Doctor Explains the Sign That Showed Up Two Years Earlier - Yahoo CreatorsYahoo Creators · Mon, 10 Aug 2026 15:00:00 GMTTenax sees 'clear path forward' for heart failure drug despite Phase III miss - FirstWord PharmaFirstWord Pharma · Mon, 10 Aug 2026 14:47:17 GMTTenax trounced by phase 3 heart failure readout - pharmaphorumpharmaphorum · Mon, 10 Aug 2026 14:13:28 GMT